ReproTox Biotech
ReproTox was founded in 2017 and specialized in developing in vitro alternative models in the fields of drug discovery, disease modeling, and toxicity screening.
26/03/2026
Thrilled to announce that our team won the 2025 RDTSS Best Paper Award at SOT in San Diego! 🏆
Our research on advanced 3D tissue models is a major win for the 3Rs (Replacement, Reduction, and Refinement). By using these New Approach Methodologies (NAMs), we are proud to advocate for animal-free studies that provide more effective and ethical results for bioscience.
So proud of the team for this recognition and for pushing the field toward a more innovative future! 🧬✨
01/04/2025
The Society of Toxicology (2025 SOT) is more than just presentations—it's a dynamic hub for idea exchange, knowledge advancement, and scientific progress. Each session sparks new perspectives, and every breakthrough moves us closer to meaningful impact. Together, we can elevate the future of science.
🔗 https://www.rptox.com/
02/11/2022
ReproTox is going to attend BioVenture 2022 hosted by The Clinical & Translational Science Center of UNM on Nov. 11, 2022. We are looking forward to meeting with colleagues of the UNM Health Sciences Center and the local biotech business community.
BioVenture_2022 CTSC BioVenture Partnership Event promotes the collaboration of New Mexico companies in the "bio" arena, investors/angels, and UNM HSC faculty and inventors. It provides access for inventors to present to experts in commercialization, economic and business development.
Haga clic aquí para reclamar su Entrada Patrocinada.
Categoría
Página web
Dirección
800 Bradbury Drive SE, Suite 150, Science & Technology Park, University Of New
Los Mochis
87106